We are live on ! Find out more
BSX icon

Boston Scientific

698 hedge funds and large institutions have $49.2B invested in Boston Scientific in 2018 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 235 increasing their positions, 239 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $232M | Put options by funds: $100M

61% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 56

20% more funds holding in top 10

Funds holding in top 10: 1518 (+3)

18% more capital invested

Capital invested by funds: $41.7B → $49.2B (+$7.52B)

4% more funds holding

Funds holding: 671698 (+27)

0.2% less ownership

Funds ownership: 92.63%92.42% (-0.2%)

2% less repeat investments, than reductions

Existing positions increased: 235 | Existing positions reduced: 239

Holders
698
Holders Change
+27
Holders Change %
+4.02%
% of All Funds
15.96%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.41%
New
90
Increased
235
Reduced
239
Closed
56
Calls
$232M
Puts
$100M
Net Calls
+$132M
Net Calls Change
+$33.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
76
Principal Financial Group
Iowa
$78.4M +$1.04M +29,761 +1%
Jennison Associates
77
Jennison Associates
New York
$77M +$563K +16,121 +0.8%
JP
78
Jana Partners
New York
$76M -$40.6M -1,162,694 -37%
Korea Investment Corp
79
Korea Investment Corp
South Korea
$73.9M +$26.1M +748,603 +64%
State Board of Administration of Florida Retirement System
80
State Board of Administration of Florida Retirement System
Florida
$73.9M -$776K -22,220 -1%
PHS
81
PFM Health Sciences
California
$73.4M +$20.6M +590,502 +45%
CS
82
Credit Suisse
Switzerland
$70M +$2.54M +72,865 +4%
Royal Bank of Canada
83
Royal Bank of Canada
Ontario, Canada
$68.9M +$16M +459,061 +35%
Ameriprise
84
Ameriprise
Minnesota
$68.4M +$3.1M +88,801 +5%
PAMU
85
Pictet Asset Management (UK)
United Kingdom
$68.2M -$4.83M -138,405 -7%
Stifel Financial
86
Stifel Financial
Missouri
$62.2M +$706K +20,202 +1%
Barclays
87
Barclays
United Kingdom
$61.9M -$15.2M -435,464 -21%
Retirement Systems of Alabama
88
Retirement Systems of Alabama
Alabama
$60M -$12.6M -360,411 -19%
BNP Paribas Asset Management
89
BNP Paribas Asset Management
France
$57.2M +$8.48M +242,668 +20%
Lord, Abbett & Co
90
Lord, Abbett & Co
New Jersey
$54.4M -$21.2M -607,419 -30%
VAM
91
Vontobel Asset Management
New York
$54.1M -$6.12M -175,321 -11%
HM
92
HealthCor Management
New York
$54M +$24.3M +695,090 +98%
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$53.7M -$5.83M -166,920 -11%
SGA
94
Sector Gamma AS
Norway
$53.3M -$2.72M -77,926 -5%
National Pension Service
95
National Pension Service
South Korea
$52M +$2.22M +63,474 +5%
ACA
96
Anchor Capital Advisors
Massachusetts
$51.9M -$1.15M -33,008 -2%
USAA
97
United Services Automobile Association
Texas
$51.9M -$75.8K -2,170 -0.2%
ACM
98
Argent Capital Management
Missouri
$50.8M +$937K +26,835 +2%
CC
99
Cannell & Co
New York
$50.5M +$1.8M +51,425 +4%
ASC
100
Atalanta Sosnoff Capital
New York
$47.2M -$749K -21,455 -2%

BSX Hedge Fund Activity: Q3 2018 in Review

698 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2018, worth a combined $49.2B — up 18% from $41.7B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new BSX positions and 56 closed out — a net gain of 34 holders — while 235 added to existing stakes and 239 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $308M. The largest seller was Capital World Investors, cutting an estimated $626M.

  • 698 institutional investors held Boston Scientific (BSX) as of Q3 2018, up from 671 in Q2 2018.
  • Funds reported $49.2B of Boston Scientific stock for Q3 2018, up 18% quarter-over-quarter.
  • 90 funds opened new Boston Scientific positions in Q3 2018 and 56 closed out, a net change of +34 holders.
  • The largest Boston Scientific buyer in Q3 2018 was Capital Research Global Investors, an estimated $308M added.
  • The largest Boston Scientific seller in Q3 2018 was Capital World Investors, an estimated $626M sold.

Based on aggregated 13F filings for Q3 2018.